Organon & Co | Aktywa



Current Assets Zmiana Data
Adcock Ingram Holdings ZAR 4.89B 194.86M 2024-06
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Celltrion KRW 5.37T 121.47B 2024-09
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Ecofibre AUD 37.37M 2.03M 2024-06
Gilead Sciences USD 19.17B 4.39B 2024-12
Glaxosmithkline GBP 17B 301M 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Malin Corporation EUR 35.9M 100K 2024-06
Medical Developments International AUD 26.14M 4.89M 2024-06
Merck USD 38.78B 1.58B 2024-12
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Organon & Co USD 4.35B 408M 2024-12
Pharma Mar EUR 250.25M 12.23M 2024-12
Qiagen NV USD 1.96B 494.22M 2024-12
Sartorius EUR 1.97B 114.6M 2024-09
Sino Biopharmaceutical CNY 24.69B 536.67M 2024-12
Tilray USD 707.34M 18.54M 2024-11



Organon & Co Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.